Beta cell adaptation in pregnancy: a major difference between humans and rodents? by Genevay, M. et al.
COMMENTARY
Beta cell adaptation in pregnancy: a major difference
between humans and rodents?
M. Genevay & H. Pontes & P. Meda
Received: 11 June 2010 /Accepted: 15 June 2010 /Published online: 10 July 2010
# Springer-Verlag 2010
Keywords Beta cell adaptation . Beta cell apoptosis . Beta
cell mass . Beta cell proliferation . CX36 . Human beta
cells . Islet neogenesis . Pregnancy . Prolactin
Increasing evidence demonstrates that the insulin-producing
beta cells can dynamically adapt their size, number and
function in response to a variety of experimental and
pathological conditions. Whether this dynamic adaptation
also takes place under physiological conditions is less clear,
with the notable exception of pregnancy [1, 2]. Under this
condition, it has long been known that rodents undergo a
rapid and substantial expansion of beta cell mass [3–5] due
to increased beta cell size (hypertrophy) and replication
(hyperplasia) [4], without detectable evidence of islet neo-
genesis [5]. These changes are induced by prolactin,
placental lactogen and growth hormone, whose receptors
are upregulated in beta cells after two-thirds of the
gestational duration [1, 6]. They are also rapidly reversed
at about the time of delivery, due to progesterone-controlled
activation of beta cell apoptosis [7]. Recent studies have
implicated selected genes controlling beta cell replication,
survival and apoptosis in these changes [8–10]. In rodents,
the changes in beta cell mass (about three- to fivefold)
cannot alone account for those in insulin output (about
eightfold), implicating a further functional improvement [1].
Thus, serum insulin increases by ∼75% due to increased
glucose-stimulated insulin secretion, and this happens despite
a 25% reduction in plasma glucose [5, 11, 12]. The increase
in glucose-stimulated insulin secretion is mostly due to a
significant decrease in the threshold for glucose stimulation
[1, 12, 13], possibly as a result of higher levels of GLUT2,
glucokinase and beta cell to beta cell coupling [13, 14].
It has also long been known that the progressive
development of insulin resistance during human pregnancy
increases the metabolic demand on beta cells, as evidenced
by increased insulin secretion [11]. Due to the difficulty of
obtaining pancreas from pregnant women, the adaptive
mechanism underlying this change remains poorly investi-
gated. However, islet enlargement, attributed to increased
beta cell proliferation and decreased beta cell apoptosis, has
been reported in a limited number of human samples [15],
suggesting that similar mechanisms are responsible for beta
cell adaptation in rodent and human pregnancy.
This tentative conclusion needs to be critically revisited
in view of recent data. First, the profile of genes that control
beta cell proliferation differs in rodents and humans [2, 16].
Second, several studies have now documented that, in
contrast with rodents, human beta cells do not proliferate
under most conditions, probably due to an age-dependent
epigenetic regulation of specific genes [17]. Moreover, a
new pathology study has now raised the possibility that the
adaptation of human beta cells to pregnancy may be
significantly less extensive than in rodents and also due to
a quite different mechanism [18]. Thus, in this issue of
Diabetologia, Butler et al. [18] document that the volume
density of beta cells was increased by only ∼1.4-fold in
human pregnancy due to increased numbers of small islets,
and not to beta cell size. These changes were associated
with increased numbers of scattered and duct-associated
beta cells, in the absence of detectable changes in beta cell
replication and apoptosis. Thus, two studies of human
samples [15, 18] concur in showing that beta cells increase
as a function of the increasing gestational demand, but they
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significantly differ in their evaluation (1) of the extent
of this adaptation, and (2) of the mechanisms responsible
for it.
Several factors may account for these differences. First,
differences in the populations studied. Thus, whereas one
study only evaluated control women who had died in car
accidents [15], the other also included women with
inflammatory diseases [18], which could potentially have
affected insulin resistance and/or altered the residual beta
cell mass. Second, the method used to track beta cells,
which was histochemical staining in one study [15] and
insulin immunostaining in the other [18]. Importantly, when
assessing the validity of these differences, the limited
number of cases investigated in both studies should be kept
in mind. Using the mean and SE values indicated in the
study by Butler et al. [18], the probability of finding a
statistically significant difference at p=0.05 can be evaluated
to provide a power of only 50% to 60%. Significantly larger
numbers of control and pregnant women would need to be
compared to reach more powerful conclusions, a limitation
inherent to most pathology studies on rare specimens.
With this caveat in mind, the new study [18] neverthe-
less suggests that rodent and human beta cells may adapt
differently to pregnancy. First, the extent of this adaptation
may be smaller in humans than in rodents. Second, the
mechanism responsible for this adaptation involves in-
creased replication and decreased apoptosis in rodents, but
possibly islet neogenesis in humans (Fig. 1). It is worth
noting that whereas all animal studies were conducted in
young animals, when the epigenetic changes that severely
restrict beta cell replication have not yet occurred [17], this
is not the case in humans, providing a possible clue as to
why no replication change was detected in the latter. In
addition, no significant change in beta cell apoptosis was
detected, in agreement with the low rate of this event in
non-pregnant humans [5]. Further, the new study [18]
provides indirect evidence that the adaptation observed in
humans may result from islet neogenesis. This finding is
relevant, inasmuch as the occurrence of islet neogenesis is
disputed in adult rodents [5, 19]. The question of whether
the contribution of this process is more important in
humans [20] requires the identification of a validated
marker for islet neogenesis that could be applied to the
study of human samples. At any rate, the Butler et al. paper
adds to the increasing literature indicating that rodent and
human islets differ in several, though not all respects [21].
Studies of other species may help clarify whether these
differences are dispensable evolutionary modifications,
whereas similarities may reflect obligatory characteristics.
It has been previously noted that the changes in beta cell
mass observed in rodent pregnancy cannot fully account for
the larger increase in insulin secretion, whereby normal
beta cells compensate for the pregnancy-related increase in
insulin resistance [1]. This implies that in the healthy
animal, beta cell function is enhanced. The mechanism of
this functional adaptation has not been fully elucidated,
even though proteins and mechanisms that could conceiv-
ably account for the enhanced beta cell function have been
identified [12–14]. The relative contribution of these
changes can now be experimentally tested, using mice
invalidated for specific beta cell proteins or mice over-
expressing them. The Butler study [18] suggests that in
humans, too, increased beta cell function, which is also
supported by increased levels of circulating C-peptide
during pregnancy in women with type 1 diabetes [22],
may be larger than the increase of beta cell mass. If the
underlying mechanism is similar in rodents and humans,
future studies should investigate beta cell proteins that are
expressed in both species and involved in the control of
insulin expression, glucose-induced insulin secretion and
beta cell survival. Among the candidates, the gap junction
protein, connexin-36, may deserve attention [1], as it is
present in rodent and human beta cells [21, 23], is linked to
insulin expression in both species [21, 23], and is required
for proper glucose-induced insulin secretion [23, 24]. The
direct exchanges of cytosolic molecules that this protein
mediates between beta cells [21, 23, 24] are increased
during rodent pregnancy [14].
Understanding the mechanisms that mediate the func-
tional adaptation of beta cells to pregnancy will explain
how insufficient adaptation leads to gestational diabetes
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Fig. 1 Beta cell mass may be differentially controlled in rodent and
human pregnancy. a The mass of beta cells results from the balance
between mechanisms that produce (cell size, replication, neogenesis
and transdifferentiation) and reduce (apoptosis and necrosis) cell size
and number. b During pregnancy, rodents increase beta cell mass by
three- to fivefold by increasing beta cell size (hypertrophy) and
replication (hyperplasia), while reducing beta cell apoptosis. c In
humans, these changes may be only 1.5-fold and due to islet
neogenesis
2090 Diabetologia (2010) 53:2089–2092
[25]. It could also provide novel insights into how to expand
the glucose-sensitive insulin-producing cells that are needed
for implementation of cell therapy in patients with diabetes.
Rodent and human studies indicate that the required beta cell
changes occur in the first third of pregnancy [2, 26], whereas
insulin resistance is established in the last third of
pregnancy [26, 27]. Thus, the factor(s) and mechanism(s)
promoting beta cell expansion and survival may be
advantageously searched for at the beginning of gestation.
In summary, animal and human studies demonstrate that
beta cells adapt to pregnancy by changing their mass and,
to an even greater degree, their function. They suggest,
however, that the mechanism responsible for the structural
beta cell adaptation may differ in the two species (Fig. 1).
This conclusion remains tentative, due to the difficulty of
assessing large numbers of women and to other limitations
of retrospective autopsy studies [15, 18], stressing the
importance of further developments in this area. Until then,
conditions inducing beta cell expansion in rodents should
not be assumed to apply to humans. Further research efforts
are now needed (see textbox) to address this question and to
better define the functional mechanisms of beta cell
adaptation. The results can be expected to lead to the
identification of new therapeutic targets, which may be
instrumental for a therapy of diabetes.
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